5.35
-0.05
(-0.93%)
At close: January 10 at 9:36:02 PM GMT+1
Loading Chart for 4KF0.SG
DELL
- Previous Close
5.40 - Open
5.20 - Bid 5.35 x --
- Ask 5.90 x --
- Day's Range
5.20 - 5.35 - 52 Week Range
5.00 - 9.25 - Volume
0 - Avg. Volume
52 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Mar 26, 2025 - Mar 31, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: 4KF0.SG
View MorePerformance Overview: 4KF0.SG
Trailing total returns as of 1/11/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
4KF0.SG
7.00%
MSCI WORLD
1.09%
1-Year Return
4KF0.SG
31.85%
MSCI WORLD
16.34%
3-Year Return
4KF0.SG
31.85%
MSCI WORLD
16.18%
5-Year Return
4KF0.SG
31.85%
MSCI WORLD
54.70%
Compare To: 4KF0.SG
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
5.35
-0.93%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
4.8250
-1.93%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
4.7420
-0.84%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
7.21
-1.57%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
1.1400
-2.56%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
7.17
-2.32%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
7.09
-1.80%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.1858
+13.29%
Mkt Cap EUR 30.241M
Industry Drug Manufacturers—Specialty & Generic
7.08
-2.82%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.3220
-3.01%
Mkt Cap EUR 111.806M
Industry Drug Manufacturers—Specialty & Generic
0.3280
-20.77%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
Statistics: 4KF0.SG
View MoreValuation Measures
As of 9/19/2024
Market Cap
425.57M
Enterprise Value
462.86M
Trailing P/E
--
Forward P/E
181.82
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.18
Price/Book (mrq)
4.27
Enterprise Value/Revenue
2.54
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--